India may have a dengue vaccine as early as next year. Developed by Japanese major Takeda, the vaccine named ‘Qdenga’ will be ...

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

Ahmedabad: After the shocking allegations of illegal clinical trials at VS Hospital, experts are now calling for stronger ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological E. Clinical trials are underway, and the company aims to ...

Seeking to ensure the quality and safety of pharmaceutical products, India's regulatory bodies have intensified their ...

Ahmedabad: A five-member investigation committee from the Ahmedabad Municipal Corporation's vigilance department has begun ...

Union Minister Dr Jitendra Singh on Thursday inspected various facilities at the BRIC-inStem facility and reviewed ongoing ...

Swasthya Adhikar Manch calls for investigation into alleged unethical clinical trials at VS Hospital in Gujarat.

A desi dengue vaccine is undergoing the third phase of clinical trials in India, a top Indian Council of Medical Research ...

Ahmedabad Municipal Corporation: "Usually, income generated from clinical trials is divided into two parts. While one part ...

Nine doctors from Ahmedabad Municipal Corporation are suspended over allegations of financial irregularities in clinical ...

The upcoming 12th Annual Clinical Trials in Oncology conference will cover a wide range of topics on clinical research in ...